Opko Net Receivables from 2010 to 2026

OPK Stock  USD 1.23  0.02  1.65%   
Opko Health Net Receivables yearly trend continues to be quite stable with very little volatility. The value of Net Receivables is projected to decrease to about 119.9 M. From the period between 2010 and 2026, Opko Health, Net Receivables regression line of its data series had sample variance of 8785.7 T and sample variance of 8785.7 T. View All Fundamentals
 
Net Receivables  
First Reported
2000-03-31
Previous Quarter
134.6 M
Current Value
124.4 M
Quarterly Volatility
102.9 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Opko Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Opko Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 118.5 M, Interest Expense of 57.3 M or Total Revenue of 435.2 M, as well as many indicators such as Price To Sales Ratio of 1.56, Dividend Yield of 0.0011 or PTB Ratio of 0.82. Opko financial statements analysis is a perfect complement when working with Opko Health Valuation or Volatility modules.
  
Build AI portfolio with Opko Stock
Check out the analysis of Opko Health Correlation against competitors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.
Historical Net Receivables data for Opko Health serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Opko Health represents a compelling investment opportunity.

Latest Opko Health's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Opko Health over the last few years. It is Opko Health's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Opko Health's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Opko Net Receivables Regression Statistics

Arithmetic Mean137,656,146
Coefficient Of Variation68.09
Mean Deviation74,341,734
Median152,048,000
Standard Deviation93,731,861
Sample Variance8785.7T
Range302.4M
R-Value0.55
Mean Square Error6554.7T
R-Squared0.30
Significance0.02
Slope10,176,090
Total Sum of Squares140570.6T

Opko Net Receivables History

2026119.9 M
2025174.9 M
2024152 M
2023130.2 M
2022148.6 M
2021265.6 M
2020302.3 M

About Opko Health Financial Statements

Opko Health investors utilize fundamental indicators, such as Net Receivables, to predict how Opko Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables174.9 M119.9 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:
Check out the analysis of Opko Health Correlation against competitors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. Anticipated expansion of Opko directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Opko Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.13)
Earnings Share
(0.24)
Revenue Per Share
0.881
Return On Assets
(0.06)
Return On Equity
(0.13)
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Opko Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Opko Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Opko Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.